Oocyte phenotype, genetic diagnosis, and clinical outcome in case of patients with oocyte maturation arrest
Backgroundoocyte maturation arrest (OMA) is currently one of the major causes of in vitro fertilization (IVF) failure, and several gene mutations were found to be associated with OMA. The purpose of this study was to identify the oocyte phenotype, genetic diagnosis, and clinical outcomes of patients...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-11-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.1016563/full |
| _version_ | 1798023121509285888 |
|---|---|
| author | Lixia Zhu Qiyu Yang Huizi Jin Juepu Zhou Meng Wang Liu Yang Zhou Li Kun Qian Lei Jin |
| author_facet | Lixia Zhu Qiyu Yang Huizi Jin Juepu Zhou Meng Wang Liu Yang Zhou Li Kun Qian Lei Jin |
| author_sort | Lixia Zhu |
| collection | DOAJ |
| description | Backgroundoocyte maturation arrest (OMA) is currently one of the major causes of in vitro fertilization (IVF) failure, and several gene mutations were found to be associated with OMA. The purpose of this study was to identify the oocyte phenotype, genetic diagnosis, and clinical outcomes of patients with OMA and explore their possible interrelationships, thus providing a more individualized and efficient treatment strategy guidance accordingly.MethodsA retrospective study was conducted, involving 28 infertile women with OMA in the Reproductive Medicine Center of Tongji Hospital from 2018 to 2021. Whole-exome sequencing was performed for the detection of gene mutations. Patients were classified into three groups based on their oocyte phenotype, and for each group, the immature oocytes were cultured in vitro and mature oocytes were fertilized to evaluate both the maturation capacity and developmental potential. The clinical outcomes of OMA patients with different gene mutations or from different groups were further analyzed and compared.ResultsTwenty-eight women with OMA were evaluated in this study. According to the stage of OMA, 14 (50.0%) women were classified as OMA Type-1 (GV arrest), 5 (17.9%) were OMA Type-2 (MI arrest), and 9 (32.1%) were OMA Type-3 (with both GV and MI arrest). Immature oocytes from OMA patients exhibited significantly lower maturation rates even after IVM, compared to those in general patients. Seven patients (25.0%) were detected to have deleterious variations in two genes (PATL2 and TUBB8), known to be associated with the OMA phenotype. Patients with identified mutations were found to have little opportunity to obtain offspring with their own oocytes. Among the patients without mutations identified, those classified as OMA Type-1 or Type-3 still had a chance to obtain offspring through IVF or natural pregnancy, while all patients in the Type-2 group failed to obtain live birth.ConclusionsThree different phenotypes were observed in patients with OMA. The clinical outcomes of patients were associated with the presence of gene mutations and the classification of oocyte phenotype, thus a reasonable triage system was proposed to optimize the allocation of health care resources and maximize patient benefit. |
| first_indexed | 2024-04-11T17:41:19Z |
| format | Article |
| id | doaj.art-8e1c27c586ef4e5ab454e12ed75a9902 |
| institution | Directory Open Access Journal |
| issn | 1664-2392 |
| language | English |
| last_indexed | 2024-04-11T17:41:19Z |
| publishDate | 2022-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj.art-8e1c27c586ef4e5ab454e12ed75a99022022-12-22T04:11:29ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-11-011310.3389/fendo.2022.10165631016563Oocyte phenotype, genetic diagnosis, and clinical outcome in case of patients with oocyte maturation arrestLixia ZhuQiyu YangHuizi JinJuepu ZhouMeng WangLiu YangZhou LiKun QianLei JinBackgroundoocyte maturation arrest (OMA) is currently one of the major causes of in vitro fertilization (IVF) failure, and several gene mutations were found to be associated with OMA. The purpose of this study was to identify the oocyte phenotype, genetic diagnosis, and clinical outcomes of patients with OMA and explore their possible interrelationships, thus providing a more individualized and efficient treatment strategy guidance accordingly.MethodsA retrospective study was conducted, involving 28 infertile women with OMA in the Reproductive Medicine Center of Tongji Hospital from 2018 to 2021. Whole-exome sequencing was performed for the detection of gene mutations. Patients were classified into three groups based on their oocyte phenotype, and for each group, the immature oocytes were cultured in vitro and mature oocytes were fertilized to evaluate both the maturation capacity and developmental potential. The clinical outcomes of OMA patients with different gene mutations or from different groups were further analyzed and compared.ResultsTwenty-eight women with OMA were evaluated in this study. According to the stage of OMA, 14 (50.0%) women were classified as OMA Type-1 (GV arrest), 5 (17.9%) were OMA Type-2 (MI arrest), and 9 (32.1%) were OMA Type-3 (with both GV and MI arrest). Immature oocytes from OMA patients exhibited significantly lower maturation rates even after IVM, compared to those in general patients. Seven patients (25.0%) were detected to have deleterious variations in two genes (PATL2 and TUBB8), known to be associated with the OMA phenotype. Patients with identified mutations were found to have little opportunity to obtain offspring with their own oocytes. Among the patients without mutations identified, those classified as OMA Type-1 or Type-3 still had a chance to obtain offspring through IVF or natural pregnancy, while all patients in the Type-2 group failed to obtain live birth.ConclusionsThree different phenotypes were observed in patients with OMA. The clinical outcomes of patients were associated with the presence of gene mutations and the classification of oocyte phenotype, thus a reasonable triage system was proposed to optimize the allocation of health care resources and maximize patient benefit.https://www.frontiersin.org/articles/10.3389/fendo.2022.1016563/fulloocyte maturation arrestIVF failureIVMgene mutationsclinical outcome |
| spellingShingle | Lixia Zhu Qiyu Yang Huizi Jin Juepu Zhou Meng Wang Liu Yang Zhou Li Kun Qian Lei Jin Oocyte phenotype, genetic diagnosis, and clinical outcome in case of patients with oocyte maturation arrest Frontiers in Endocrinology oocyte maturation arrest IVF failure IVM gene mutations clinical outcome |
| title | Oocyte phenotype, genetic diagnosis, and clinical outcome in case of patients with oocyte maturation arrest |
| title_full | Oocyte phenotype, genetic diagnosis, and clinical outcome in case of patients with oocyte maturation arrest |
| title_fullStr | Oocyte phenotype, genetic diagnosis, and clinical outcome in case of patients with oocyte maturation arrest |
| title_full_unstemmed | Oocyte phenotype, genetic diagnosis, and clinical outcome in case of patients with oocyte maturation arrest |
| title_short | Oocyte phenotype, genetic diagnosis, and clinical outcome in case of patients with oocyte maturation arrest |
| title_sort | oocyte phenotype genetic diagnosis and clinical outcome in case of patients with oocyte maturation arrest |
| topic | oocyte maturation arrest IVF failure IVM gene mutations clinical outcome |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2022.1016563/full |
| work_keys_str_mv | AT lixiazhu oocytephenotypegeneticdiagnosisandclinicaloutcomeincaseofpatientswithoocytematurationarrest AT qiyuyang oocytephenotypegeneticdiagnosisandclinicaloutcomeincaseofpatientswithoocytematurationarrest AT huizijin oocytephenotypegeneticdiagnosisandclinicaloutcomeincaseofpatientswithoocytematurationarrest AT juepuzhou oocytephenotypegeneticdiagnosisandclinicaloutcomeincaseofpatientswithoocytematurationarrest AT mengwang oocytephenotypegeneticdiagnosisandclinicaloutcomeincaseofpatientswithoocytematurationarrest AT liuyang oocytephenotypegeneticdiagnosisandclinicaloutcomeincaseofpatientswithoocytematurationarrest AT zhouli oocytephenotypegeneticdiagnosisandclinicaloutcomeincaseofpatientswithoocytematurationarrest AT kunqian oocytephenotypegeneticdiagnosisandclinicaloutcomeincaseofpatientswithoocytematurationarrest AT leijin oocytephenotypegeneticdiagnosisandclinicaloutcomeincaseofpatientswithoocytematurationarrest |